Literature DB >> 79613

Macrophage-lymphocyte interaction in migration inhibition factor (MIF) production against soluble or cellular tumor-associated antigens. I. Characteristics and genetic control of two different mechanisms of stimulating MIF production.

S Landolfo, R B Herberman, H T Holden.   

Abstract

For MIF production in response to 3 M KCl extracts of tumor, viable and metabolically active macrophages have been shown to be required to interact with the soluble tumor antigens and then come in contact with immune lymphocytes. The Mphi-lymphocyte interaction for MIF production was found to be under the control of genes mapping in the IA subregion of the H-2 complex. However, when intact tumor cells were used as antigen, Mphi were not required for immune lymphocytes to produce MIF. In addition, the interaction of immune lymphocytes with tumor cells for MIF production did not require H-2 compatibility. These and other observations strongly suggest that there are two different mechanisms for MIF production and that these may be mediated by two separate subpopulations of immune lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 79613

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Evidence for macrophage-mediated protection against lethal Candida albicans infection.

Authors:  F Bistoni; A Vecchiarelli; E Cenci; P Puccetti; P Marconi; A Cassone
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

2.  HLA-B8 and cell-mediated immunity to gluten.

Authors:  F G Simpson; A W Bullen; D A Robertson; M S Losowsky
Journal:  Gut       Date:  1981-08       Impact factor: 23.059

Review 3.  The role of lymphokines in delayed-type hypersensitivity reactions.

Authors:  C L Geczy
Journal:  Springer Semin Immunopathol       Date:  1984

4.  Induction of natural killer cell activity by inactivated Candida albicans in mice.

Authors:  P Marconi; L Scaringi; L Tissi; M Boccanera; F Bistoni; E Bonmassar; A Cassone
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

5.  Enhancement of natural killer cell activity in mice by treatment with a thymic factor.

Authors:  F Bistoni; M Baccarini; P Puccetti; P Marconi; E Garaci
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

6.  Interaction of subpopulations of murine lymph node lymphocytes in antigen-induced [14C]-thymidine incorporation: T and B cell synergy in the response to antigen.

Authors:  E Brummer; N Bhardwaj; H S Lawrence
Journal:  Immunology       Date:  1979-10       Impact factor: 7.397

7.  Natural cell-mediated cytotoxicity against Candida albicans induced by cyclophosphamide: nature of the in vitro cytotoxic effector.

Authors:  M Baccarini; F Bistoni; P Puccetti; E Garaci
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.